Project Grant HT94252510297
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$2.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
South Miami, FL 33146, USA
Similar Awards
The Defense Health Agency awarded a $4.66 million project grant to the University of Colorado Denver to support research on a stem cell-based therapy for recessive dystrophic epidermolysis bullosa delivered with a spray-on skin device. The grant was awarded on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420) and will run through August 31, 2027. Through this funding, the University of Colorado Denver will conduct research to develop an innovative stem...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,352,128.00 to the University of Miami for the development of human iPSC-derived chromaffin cell transplants for the treatment of chronic pain. The three-year award, which began on July 15, 2024 and runs through July 14, 2027, supports the university's research to investigate innovative therapeutic approaches for addressing chronic pain conditions...
The Defense Health Agency awarded The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, a $1,986,275 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of biofabricated, patient-specific skin gloves as a personalized therapy for mitten deformities in epidermolysis bullosa, a rare genetic skin disorder. The project will run from June 15, 2023 to June 14, 2027. The Military...
This Project Grant award of $1,558,753.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the University of Cincinnati in conducting tissue engineering research for cutaneous and systemic epidermolysis bullosa gene therapy. The award period runs from September 1, 2023 to August 31, 2026. The University of Cincinnati, through its Sponsored Research Services Division, is the prime awardee on this grant. As a subcontractor, the...
The University of Miami received a $153,500 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENGINEERING TARGETED EXOSOME-BASED THERAPEUTICS FOR REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS IN TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER". The 2-year award period runs from February 15, 2024 to February 14, 2026. The Project Grant supports the university's work to develop novel...
The University of Miami was awarded a $1,700,000 Project Grant from the Department of Defense Broad Agency Announcement on September 15, 2024. The funding will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, as part of the Military Medical Research and Development (CFDA 12.420) federal grant program. The university will conduct scientific investigations spanning basic, applied, and translational research...
The University of Miami received a $921,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 15, 2021 will support single-cell analysis of LAG3 checkpoint inhibition in metastatic uveal melanoma. Through this research, the University aims to transform health care for service members and the public by investigating medical solutions for the...
This $1,347,118 Project Grant was awarded on May 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research conducted by the University of Miami to target KIF20A, a kinesin with a novel, non-canonical role in castration-resistant prostate cancer. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research investigating medical...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $301,000.00 to the University of Miami to develop an eHealth psychosocial stress and symptom management intervention for patients with pancreatic cancer. The project aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and management....